-
This is the second of a two-part series on error disclosure to emergency department patients. This month, we give specific steps to take before apologizing to a patient.
-
An emergency provider, you are driving down a busy interstate when you see an accident occur between two vehicles. Are you required to stop and render aid? Is calling 9-1-1 and continuing on your drive acceptable?
-
Thrombopoietin receptor agonists such as romiplostim and eltrombopag have recently been approved to raise platelet counts in patients with immune thrombocytopenic purpura (ITP). One unusual side effect has been increased bone marrow reticulin fibrosis.
-
Elderly patients with diffuse large cell lymphomas were assessed for the presence of various factors that might influence clinical outcomes from aggressive therapy.
-
Examining data from a randomized trial of two different chemotherapy regimens for non-small cell lung cancer, Kishida et al found that chemotherapy-induced neutropenia is a predictor of better survival. The authors call for future trials in which dose increases are employed in the absence of neutropenia or other chemotherapy-induced toxicity.
-
-
The authors assessed 151 consecutive patients with gastroesophageal adenocarcinoma who had chemoradiation and surgery.
-
Metronomic chemotherapy implies the use of a lower-dose agent over protracted periods of time. In the current phase I trial, vinorelbine was administered orally, three times weekly to 62 patients at various escalating doses, and it was determined that 50 mg/dose was optimal.
-
Efficacy of once-daily insulin, aldo-sterone use in heart failure, erectile dysfunction Clinical Practice Guidelines, and FDA Actions.
-
Percutaneous coronary intervention (PCI) with bare-metal stents (BMS) or drug-eluting stents (DES) remains the most common method of coronary revascularization.
